<DOC>
	<DOCNO>NCT01610778</DOCNO>
	<brief_summary>This study design evaluate efficacy 5-aminolevulinic acid subject type 2 diabetes medication .</brief_summary>
	<brief_title>Effects 5-Aminolevulinic Acid Glucose Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Type 2 diabetic patient medication HbA1c ≤ 9.0 % ( JDS value , equivalent HbA1c ≤ 9.4 % NGSP value ) On stable treatment diabetes least last 3 month With permission attend clinical trial primary doctor On insulin therapy BMI ≤ 18 kg/m2 ≥ 30 kg/m2 History porphyria , hemochromatosis , viral hepatitis Pregnant nursing child Heart disease Renal hepatic dysfunction Participation clinical trial within 90 day commencement trial</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>